These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10788597)

  • 1. Anti-HIV-1 integrase drugs: how far from the shelf?
    Pani A; Marongiu ME
    Curr Pharm Des; 2000 Mar; 6(5):569-84. PubMed ID: 10788597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel inhibitors of HIV-1 integration.
    Witvrouw M; Van Maele B; Vercammen J; Hantson A; Engelborghs Y; De Clercq E; Pannecouque C; Debyser Z
    Curr Drug Metab; 2004 Aug; 5(4):291-304. PubMed ID: 15320701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress in the development of inhibitors of human immunodeficiency virus (HIV) integrase for the management of HIV infection.
    Lin SS; Xu F; Liao PH; Yang CC
    Acta Virol; 2008; 52(4):197-207. PubMed ID: 19143475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV type 1 integrase inhibitors: from basic research to clinical implications.
    Jegede O; Babu J; Di Santo R; McColl DJ; Weber J; Quiñones-Mateu M
    AIDS Rev; 2008; 10(3):172-89. PubMed ID: 18820719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational design of 2-pyrrolinones as inhibitors of HIV-1 integrase.
    Ma K; Wang P; Fu W; Wan X; Zhou L; Chu Y; Ye D
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6724-7. PubMed ID: 21996518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In search of authentic inhibitors of HIV-1 integration.
    Debyser Z; Cherepanov P; Van Maele B; De Clercq E; Witvrouw M
    Antivir Chem Chemother; 2002 Jan; 13(1):1-15. PubMed ID: 12180645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of N-methylpyrimidone derivatives as HIV-1 integrase inhibitors.
    Wang Y; Rong J; Zhang B; Hu L; Wang X; Zeng C
    Bioorg Med Chem; 2015 Feb; 23(4):735-41. PubMed ID: 25618597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV-1 integrase: a target for new AIDS chemotherapeutics.
    Anthony NJ
    Curr Top Med Chem; 2004; 4(9):979-90. PubMed ID: 15134552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Past and future. Current drugs targeting HIV-1 integrase and reverse transcriptase-associated ribonuclease H activity: single and dual active site inhibitors.
    Esposito F; Tramontano E
    Antivir Chem Chemother; 2014 Jan; 23(4):129-44. PubMed ID: 24150519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic potential of peptide motifs against HIV-1 reverse transcriptase and integrase.
    Andréola ML
    Curr Pharm Des; 2009; 15(21):2508-19. PubMed ID: 19601847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance against Integrase Strand Transfer Inhibitors and Relevance to HIV Persistence.
    Mesplède T; Wainberg MA
    Viruses; 2015 Jul; 7(7):3703-18. PubMed ID: 26198244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches.
    Tarrago-Litvak L; Andreola ML; Fournier M; Nevinsky GA; Parissi V; de Soultrait VR; Litvak S
    Curr Pharm Des; 2002; 8(8):595-614. PubMed ID: 11945161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing HIV integrase inhibitors--shooting the last arrow.
    Makhija MT
    Curr Med Chem; 2006; 13(20):2429-41. PubMed ID: 16918363
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV integrase inhibitors as therapeutic agents in AIDS.
    Nair V; Chi G
    Rev Med Virol; 2007; 17(4):277-95. PubMed ID: 17503547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perspectives on developing small molecule inhibitors targeting HIV-1 integrase.
    Tan JJ; Liu C; Sun XH; Cong XJ; Hu LM; Wang CX; Liang XJ
    Mini Rev Med Chem; 2012 Aug; 12(9):875-89. PubMed ID: 22512579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 integrase inhibitors: 2005-2006 update.
    Dayam R; Gundla R; Al-Mawsawi LQ; Neamati N
    Med Res Rev; 2008 Jan; 28(1):118-54. PubMed ID: 17979144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel inhibitors of HIV integrase: the discovery of potential anti-HIV therapeutic agents.
    Nair V
    Curr Pharm Des; 2003; 9(31):2553-65. PubMed ID: 14529542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The future of integrase inhibitors of HIV-1.
    Malet I; Calvez V; Marcelin AG
    Curr Opin Virol; 2012 Oct; 2(5):580-7. PubMed ID: 22980926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemical screening assays to identify HIV-1 integrase inhibitors.
    Clynhens M; Smets A; Vereycken I; Van Loock M; Clayton R; Meersseman G; Goethals O
    Methods Mol Biol; 2013; 1030():25-36. PubMed ID: 23821258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of 3-hydroxy-3-phenylpropanoate ester–AZT conjugates as potential dual-action HIV-1 Integrase and Reverse Transcriptase inhibitors.
    Manyeruke MH; Olomola TO; Majumder S; Abrahams S; Isaacs M; Mautsa N; Mosebi S; Mnkandhla D; Hewer R; Hoppe HC; Klein R; Kaye PT
    Bioorg Med Chem; 2015 Dec; 23(24):7521-8. PubMed ID: 26775541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.